Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00394199 · ClinicalTrials.gov registry record · Phase 3
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma
A Phase 3 study, sponsored by SkyePharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 357
- Enrollment target
NCT00394199: Completed Phase 3 study, sponsored by SkyePharma.
NCT00394199 is a Phase 3 study that has completed, run by SkyePharma. The registered enrollment target is 357 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (54% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00394199, a Phase 3 study, has completed, sponsored by SkyePharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 357 participants
- Enrollment target
Study Summary
To compare the efficacy and safety of the fixed combination asthma drug Flutiform HFA MDI with its two components administered alone, fluticasone propionate and formoterol fumarate, in adult and adolescent patients with mild to moderate asthma.
Interventions
- DRUG Formoterol fumarate 10
- DRUG Fluticasone propionate/Formoterol Fumarate 100/10
- DRUG Fluticasone propionate 100
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 357 participants |
| Start Date | 2006-06 |
| Est. Completion | 2008-02 |
| Phase | Phase 3 |
What the finished NCT00394199 record still lists
NCT00394199 is an interventional study that assigns participants to a tested intervention. The registered 357 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (54% lower).
The record links to 0 conditions, and to 3 interventions - of which Formoterol fumarate 10 is the first listed.
NCT00394199 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00394199 about?
NCT00394199 is a clinical study titled "Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma". To compare the efficacy and safety of the fixed combination asthma drug Flutiform HFA MDI with its two components administered alone, fluticasone propionate and formoterol fumarate, in adult and adolescent patients with mild to moderate asthma.
What is the current status of trial NCT00394199?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 357 participants. The study started on 2006-06. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00394199?
The interventions under investigation include: Formoterol fumarate 10 (DRUG), Fluticasone propionate/Formoterol Fumarate 100/10 (DRUG), Fluticasone propionate 100 (DRUG).
Who is sponsoring clinical trial NCT00394199?
This trial is sponsored by SkyePharma, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00394199's enrollment target sits among peer trials
357 1023rd of 2000 higher than 977 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06062888 · 357 participants · Phase 2
FFP In Traumatic BRAin INjury (FIT-BRAIN) Trial
- NCT06109766 · 357 participants · NA
Delivering Evidence-Based Parenting Services to Families in Child Welfare Using Telehealth
- NCT06231342 · 357 participants · NA
Endotracheal Tube (ETT) 180: Stylet-loaded Endotracheal Tube Rotation Before Insertion
- NCT06533826 · 357 participants · Phase 2
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia